Slide 1: First Quarter 2026 Earnings
Click Here to Edit Title First Quarter 2026 Earnings April 29, 2026
Slide 2: Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures
Cautionary Click Here to Statement Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements ma
Slide 3: IDEX 1Q26 Highlights
Click Here IDEX 1Q26 to Edit Title Highlights Delivered better than expected top and bottom line results Business portfolio pivot toward advantaged markets and integrated growth strategies driving record backlog in HST Industrial businesses showing signs of stability/support, tracking external indic
Slide 4: Growing in Advantaged Markets: Space & Defense
Growing In Advantaged Click Here Title Space & Defense to EditMarkets: Increasing already extensive content in market growing double-digits Porous Filtration Optical Solutions Durable Clamping & Flow Control Optical sensing and communication Filtration and flow control solutions from BAND-IT stainle
Slide 5: 8020 Drives Growth
8020 ClickDrives Growth Here to Edit Title 80s Markets • Space & Defense, Semiconductor, Data Center • High-value, application-critical end markets where our 8020 in Practice expertise drives durable growth and deeper customer Growth through focus over time integration 80s Customers • Global OEMs an
Slide 6: Q1 2026 Financial Performance
Q1 Click 2026 Here Financial to Edit Title Performance ($ in millions excl. EPS) Sales Adj. EBITDA Margin* Adj. EPS* Free Cash Flow* +5% Organic* +50 bps +14% (6%) Better than expected 1Q26 results across IDEX *This presentation contains non-GAAP financial information whose reconciliations are inclu
Slide 7: Q1 2026: Health & Science Technologies Performance Highlights
Q1 Click 2026: HereHealth to Edit&Title ($ in millions) Science Technologies Performance Highlights Orders Sales Adj. EBITDA Margin +17% Organic* +11% Organic* +100 bps y/y • Momentum and backlog building in businesses tied to advantaged markets • Seeing particularly strong demand in AI-driven areas
Slide 8: Q1 2026: Fluid & Metering Technologies Performance Highlights
Q1 Click 2026: HereFluid to Edit ($ in millions) & Metering Title Technologies Performance Highlights Orders Sales Adj. EBITDA Margin +9% Organic* +2% Organic* (10) bps y/y • Leading indicator general industrial businesses signaling stability • Demand for FMT’s water and mining applications remains
Slide 9: Q1 2026: Fire & Safety / Diversified Products Performance Highlights
Q1 Click 2026: HereFire to Edit ($ in millions) & Safety Title / Diversified Products Performance Highlights Orders Sales Adj. EBITDA Margin (4%) Organic* (1%) Organic* +30 bps y/y • Fire & Safety businesses seeing strong demand in North America and relative stability in Europe & Asia • BAND-IT mixe
Slide 10: Capital Deployment
Click Here Capital to Edit Title Deployment Maintaining a balanced and returns-oriented approach Gross Leverage* Capital Deployment (’25 vs. ’26) IDEX Capital Deployment Framework ($ in millions) Maintain • Maintain investment grade 2.2x $147 flexible credit rating 2.0x balance sheet • Gross leverag
Slide 11: 2026 Guidance Summary
2026 Click Here Guidance to Edit Summary Title FY26 FY26 2Q26 Current Previous Organic* Revenue Growth y/y 3.0% - 4.0% 3.0% - 4.0% 1.0% - 2.0% Adjusted EBITDA Margin* 26.5% - 27.0% 26.5% - 27.0% 26.5% - 27.0% Adjusted EPS* $2.07 - $2.12 $8.35 - $8.55 $8.15 - $8.35 Other Modeling Items: (a) FX Impact
Slide 12: IDEX Value Drivers
Click Value IDEX Here to Edit Title Drivers Differentiated 8020 operating model drives full business potential through simplification, focused resourcing and streamlined execution Focused on continuously evolving our portfolio toward high-growth, advantaged markets with secular tailwinds Balanced al
Slide 13: Non-GAAP Reconciliations
Click Here to Edit Title Non-GAAP Reconciliations
Slide 14: Table 1: Reconciliations of the Change in Net Sales to Organic Sales
Click Here to Edit Title Table 1: Reconciliations of the Change in Net Sales to Organic Sales HST FMT FSDP IDEX Three Months Ended March 31, 2026 Change in net sales 17% 4% 2% 9% Less: Net impact from acquisitions/divestitures(1) 3% —% —% 1% Impact from foreign currency(2) 3% 2% 3% 3% Change in orga
Slide 15: Table 2: Reconciliations of Reported-to-Adjusted Net Income and Diluted EPS
Click Here to Edit Title Table 2: Reconciliations of Reported-to-Adjusted Net Income Attributable to IDEX and Diluted EPS Attributable to IDEX (in millions, except per share amounts) Three Months Ended March 31, 2026 2025 Reported net income attributable to IDEX $ 120.0 $ 95.5 Restructuring expenses
Slide 16: Table 3: Reconciliations of Net Income to Adjusted EBITDA
Click Here to Edit Title Table 3: Reconciliations of Net Income to Adjusted EBITDA (dollars in millions) Three Months Ended March 31, 2026 2025 Reported net income $ 119.9 $ 95.4 Provision for income taxes 37.1 29.1 Interest expense - net 16.0 16.1 Depreciation 19.9 18.4 Amortization 33.8 31.5 Restr
Slide 17: Table 3: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow
Click Here to Edit Title Table 3: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow (dollars in millions) Three Months Ended March 31, 2026 2025 Cash flows from operating activities $ 103.7 $ 105.7 Less: Capital expenditures 17.7 14.3 Free cash flow $ 86.0 $ 91.4 Reported net